Roche buys US diagnostics company IQuum in $567 million deal

Roche buys US diagnostics company IQuum in $567 million deal
A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012.

ZURICH - Swiss drugmaker Roche has agreed to buy privately-held US diagnostics company IQuum in a deal worth up to US$450 million (S$567 million) to strengthen its molecular diagnostics business.

The Basel-based firm said it will pay IQuum shareholders US$275 million upfront and up to US$175 million in contingent product-related milestones. "With IQuum, we further strengthen our molecular diagnostics offerings with cutting-edge technology and products that serve the point of care segment," said Roland Diggelmann, head of Roche's diagnostics division, in a statement on Monday.

More about

Purchase this article for republication.

BRANDED CONTENT

SPONSORED CONTENT

Your daily good stuff - AsiaOne stories delivered straight to your inbox
By signing up, you agree to our Privacy policy and Terms and Conditions.